{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:01Z","timestamp":1792788481585,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fralin Biomedical Research Institute","id":[{"id":"https:\/\/ror.org\/03yr0pg70","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cannabis use has increased dramatically in the past decade and is currently among the most commonly used drugs in the world. Among people in recovery from substance use disorders (SUDs), cannabis is sometimes put forward as a less harmful substitute for other drugs, conflicting with abstinence-based recovery approaches. We aimed to describe cannabis use among people in recovery, explore relations among cannabis use (CU) status (Current-CU, Former-CU, Never-CU) and beliefs about social acceptability, safety, benefits, risks, and addictiveness of cannabis, and compare beliefs about the addictiveness of cannabis with that of other substances.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study was a cross-sectional, online survey of people in recovery (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009507) from SUDs. Cannabis use and beliefs about acceptability, benefits, risks, safety, and addictiveness were assessed, and diagnostic criteria for SUDs, including cannabis use disorder (CUD).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Participants were, on average, 47.2 (SD\u2009=\u200912.2) years old, 67.3% female, 81.1% White, and 93.7% non-Hispanic\/Latino; 35.9% and 51.3% indicated Current- or Former-CU, respectively. Current-CU was associated with use for therapeutic purposes, and more positive beliefs about the acceptability (\n                      <jats:italic>p<\/jats:italic>\n                      s\u2009\u2264\u2009.010), safety (\n                      <jats:italic>p<\/jats:italic>\n                      s\u2009&lt;\u2009.001), and benefits of cannabis, and risks compared to Former- or Never-CU. Those who never used cannabis rated cannabis as the least socially acceptable (\n                      <jats:italic>p<\/jats:italic>\n                      s\u2009\u2264\u2009.015), least safe (\n                      <jats:italic>p<\/jats:italic>\n                      s\u2009\u2264\u2009.036), and were least likely to endorse potential benefits. Individuals who formerly used cannabis generally showed intermediate beliefs. All participants believed cannabis was less addictive than alcohol (\n                      <jats:italic>p<\/jats:italic>\n                      s\u2009&lt;\u2009.001), cigarettes (\n                      <jats:italic>p<\/jats:italic>\n                      s\u2009&lt;\u2009.001), and cocaine (\n                      <jats:italic>p<\/jats:italic>\n                      s\u2009&lt;\u2009.001), but Current-CU believed cannabis was significantly less addictive (\n                      <jats:italic>p<\/jats:italic>\n                      s\u2009&lt;\u2009.001) than Former- and Never-CU. Participants with mild CUD believed cannabis was less addictive than those with severe CUD. Among participants with other SUDs, beliefs about the addictiveness of the respective substance did not differ by SUD severity (\n                      <jats:italic>p<\/jats:italic>\n                      s\u2009\u2265\u2009.298).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings underscore the importance of recognizing heterogeneity in cannabis use among people in recovery. Those with mild CUD believed cannabis was the least addictive while those with severe CUD believed cannabis was most addictive. In contrast, beliefs about the addictiveness of other substances were independent of SUD severity. This pattern of beliefs about addictiveness appears to be specific to cannabis. Understanding beliefs about cannabis use among people in recovery may clarify its impact on recovery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42238-026-00461-5","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:46:08Z","timestamp":1783071968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cannabis use and beliefs among people in recovery from substance use disorders"],"prefix":"10.1186","volume":"8","author":[{"given":"Anthony N.","family":"Nist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Sheffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Nusair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison N.","family":"Tegge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"461_CR2","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1176\/appi.ajp.162.8.1507","volume":"162","author":"E Aharonovich","year":"2005","unstructured":"Aharonovich E, et al. Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study. Am J Psychiatry. 2005;162:1507\u201314.","journal-title":"Am J Psychiatry"},{"key":"461_CR3","doi-asserted-by":"publisher","unstructured":"American Psychiatric Association. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. (American Psychiatric Association. https:\/\/doi.org\/10.1176\/appi.books.9780890425596, 2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"461_CR25","unstructured":"American Psychiatric Association. New APA Poll Finds Americans Rate Cigarettes as Most Unsafe, Addictive Substance Among Options Surveyed. [Internet]. 2023 Jun 8. Available from: https:\/\/www.psychiatry.org\/news-room\/news-releases\/new-apa-poll-finds-americans-rate-cigarettes-as-mo"},{"key":"461_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.drugalcdep.2018.11.012","volume":"195","author":"BJ Arterberry","year":"2019","unstructured":"Arterberry BJ, Treloar Padovano H, Foster KT, Zucker RA, Hicks BM. Higher average potency across the United States is associated with progression to first cannabis use disorder symptom. Drug Alcohol Depend. 2019;195:186\u201392.","journal-title":"Drug Alcohol Depend"},{"key":"461_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12954-024-01002-0","volume":"21","author":"CA Beaugard","year":"2024","unstructured":"Beaugard CA, Walley AY, Amodeo M. \u2018Everything is kind of the same except my mind is with me\u2019: exploring cannabis substitution in a sample of adults in early recovery from an opioid or stimulant addiction. Harm Reduct J. 2024;21:83.","journal-title":"Harm Reduct J"},{"key":"461_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"Suppl 1","key":"461_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1360-0443.2006.01582.x","volume":"101","author":"AJ Budney","year":"2006","unstructured":"Budney AJ. Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue? Addiction. 2006;101(Suppl 1):125\u201333.","journal-title":"Addiction"},{"key":"461_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1037\/1064-1297.6.4.419","volume":"6","author":"AJ Budney","year":"1998","unstructured":"Budney AJ, Radonovich KJ, Higgins ST, Wong CJ. Adults seeking treatment for marijuana dependence: A comparison with cocaine-dependent treatment seekers. Exp Clin Psychopharmacol. 1998;6:419\u201326.","journal-title":"Exp Clin Psychopharmacol"},{"key":"461_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00406-018-0976-1","volume":"269","author":"AJ Budney","year":"2019","unstructured":"Budney AJ, Sofis MJ, Borodovsky JT. An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use. Eur Arch Psychiatry Clin Neurosci. 2019;269:73\u201386.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"461_CR11","doi-asserted-by":"publisher","first-page":"111395","DOI":"10.1016\/j.drugalcdep.2024.111395","volume":"262","author":"DAR Cabral","year":"2024","unstructured":"Cabral DAR, et al. Associations between delay discounting and unhealthy behaviors in substance use recovery. Drug Alcohol Depend. 2024;262:111395.","journal-title":"Drug Alcohol Depend"},{"key":"461_CR12","unstructured":"Cannabis Potency Data. National Institute on Drug Abuse Research Data, Measure, & Resources https:\/\/nida.nih.gov\/research\/research-data-measures-resources\/cannabis-potency-data (2024)."},{"key":"461_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ypmed.2017.07.008","volume":"104","author":"H Carliner","year":"2017","unstructured":"Carliner H, Brown QL, Sarvet AL, Hasin DS. Cannabis use, attitudes, and legal status in the U.S. A review. Prev Med. 2017;104:13\u201323.","journal-title":"Prev Med"},{"key":"461_CR14","doi-asserted-by":"publisher","first-page":"e0230167","DOI":"10.1371\/journal.pone.0230167","volume":"15","author":"MC Cash","year":"2020","unstructured":"Cash MC, Cunnane K, Fan C, Romero-Sandoval EA. Mapping cannabis potency in medical and recreational programs in the United States. PLoS ONE. 2020;15:e0230167.","journal-title":"PLoS ONE"},{"key":"461_CR15","unstructured":"Centers for Disease Control and Prevention. Marijuana and Public Health: Data and Statistics. Retrieved from Centers for Disease Control and Prevention: https:\/\/www.cdc.gov\/marijuana\/data-statistics.htm 2021."},{"key":"461_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/ajad.13390","volume":"32","author":"AM Cohn","year":"2023","unstructured":"Cohn AM, et al. Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment. Am J Addict. 2023;32:333\u201342.","journal-title":"Am J Addict"},{"key":"461_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-021-00247-4","volume":"7","author":"JP Connor","year":"2021","unstructured":"Connor JP, et al. Cannabis use and cannabis use disorder. Nat Rev Dis Primers. 2021;7:16.","journal-title":"Nat Rev Dis Primers"},{"key":"461_CR18","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/add.15743","volume":"117","author":"JP Connor","year":"2022","unstructured":"Connor JP, Stjepanovi\u0107 D, Budney AJ, Le Foll B, Hall WD. Clinical management of cannabis withdrawal. Addiction. 2022;117:2075\u201395.","journal-title":"Addiction"},{"key":"461_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/10550490600754341","volume":"15","author":"ML Copersino","year":"2006","unstructured":"Copersino ML, et al. Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use. Am J Addict. 2006;15:297\u2013302.","journal-title":"Am J Addict"},{"key":"461_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1590\/1516-4446-2020-1416","volume":"43","author":"C de Meneses-Gaya","year":"2021","unstructured":"de Meneses-Gaya C, et al. Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study. Rev Bras Psiquiatr. 2021;43:467\u201376.","journal-title":"Rev Bras Psiquiatr"},{"key":"461_CR21","doi-asserted-by":"publisher","first-page":"104782","DOI":"10.1016\/j.drugpo.2025.104782","volume":"140","author":"A Doggett","year":"2025","unstructured":"Doggett A, et al. Changes in cannabis attitudes and perceptions in the five years following recreational legalization in Canada: Findings from an observational cohort study of community adults. Int J Drug Policy. 2025;140:104782.","journal-title":"Int J Drug Policy"},{"key":"461_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3109\/16066359.2011.618957","volume":"20","author":"C Duff","year":"2012","unstructured":"Duff C, et al. A Canadian perspective on cannabis normalization among adults. Addict Res Theory. 2012;20:271\u201383.","journal-title":"Addict Res Theory"},{"key":"461_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/acer.14765","volume":"46","author":"D Eddie","year":"2022","unstructured":"Eddie D, Bergman BG, Hoffman LA, Kelly JF. Abstinence versus moderation recovery pathways following resolution of a substance use problem: Prevalence, predictors, and relationship to psychosocial well-being in a US national sample. Alcohol Clin Exp Res. 2022;46:312\u201325.","journal-title":"Alcohol Clin Exp Res"},{"key":"461_CR24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.addbeh.2005.05.033","volume":"31","author":"TP Ellingstad","year":"2006","unstructured":"Ellingstad TP, Sobell LC, Sobell MB, Eickleberry L, Golden CJ. Self-change: A pathway to cannabis abuse resolution. Addict Behav. 2006;31:519\u201330.","journal-title":"Addict Behav"},{"key":"461_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/inm.13231","volume":"33","author":"F Fehr","year":"2024","unstructured":"Fehr F, et al. Stigma-related barriers to medical cannabis as harm reduction for substance use disorder: Obstacles and opportunities for improvement. Int J Ment Health Nurs. 2024;33:195\u2013201.","journal-title":"Int J Ment Health Nurs"},{"key":"461_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/16066359.2023.2221029","volume":"32","author":"AR Florimbio","year":"2024","unstructured":"Florimbio AR, et al. Direct and indirect effects of cannabis risk perceptions on cannabis use frequency. Addict Res Theory. 2024;32:68\u201373.","journal-title":"Addict Res Theory"},{"key":"461_CR28","doi-asserted-by":"publisher","first-page":"112525","DOI":"10.1016\/j.drugalcdep.2024.112525","volume":"267","author":"RM Fontes","year":"2025","unstructured":"Fontes RM, Tegge AN, Freitas-Lemos R, Cabral D, Bickel WK. Beyond the first try: How many quit attempts are necessary to achieve substance use cessation? Drug Alcohol Depend. 2025;267:112525.","journal-title":"Drug Alcohol Depend"},{"key":"461_CR29","doi-asserted-by":"publisher","first-page":"e0187633","DOI":"10.1371\/journal.pone.0187633","volume":"12","author":"AM Franklyn","year":"2017","unstructured":"Franklyn AM, Eibl JK, Gauthier GJ, Marsh DC. The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario. Canada Plos One. 2017;12:e0187633.","journal-title":"Canada Plos One"},{"key":"461_CR30","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1007\/s11469-024-01287-z","volume":"23","author":"AD Gallassi","year":"2025","unstructured":"Gallassi AD, et al. Cannabidiol compared to pharmacological treatment as usual for crack use disorder: A feasibility, preliminary efficacy, parallel, double-blind, randomized clinical trial. Int J Ment Health Addict. 2025;23:3222\u201346.","journal-title":"Int J Ment Health Addict"},{"key":"461_CR31","doi-asserted-by":"publisher","first-page":"1275975","DOI":"10.3389\/fpubh.2023.1275975","volume":"11","author":"S Giorgi","year":"2023","unstructured":"Giorgi S, Habib DRS, Bellew D, Sherman G, Curtis B. A linguistic analysis of dehumanization toward substance use across three decades of news articles. Front Public Health. 2023;11:1275975.","journal-title":"Front Public Health"},{"key":"461_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/her\/cyac006","volume":"37","author":"S Goodman","year":"2022","unstructured":"Goodman S, Hammond D. Perceptions of the health risks of cannabis: estimates from national surveys in Canada and the United States, 2018\u20132019. Health Educ Res. 2022;37:61\u201378.","journal-title":"Health Educ Res"},{"key":"461_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3109\/10826084.2014.984847","volume":"50","author":"D Grevenstein","year":"2015","unstructured":"Grevenstein D, Nagy E, Kroeninger-Jungaberle H. Development of risk perception and substance use of tobacco, alcohol and cannabis among adolescents and emerging adults: evidence of directional influences. Subst Use Misuse. 2015;50:376\u201386.","journal-title":"Subst Use Misuse"},{"key":"461_CR34","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/S0140-6736(09)61037-0","volume":"374","author":"W Hall","year":"2009","unstructured":"Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374:1383\u201391.","journal-title":"Lancet"},{"key":"461_CR35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-devpsych-040320-084904","volume":"2","author":"W Hall","year":"2020","unstructured":"Hall W, Leung J, Lynskey M. The effects of cannabis use on the development of adolescents and young adults. Annu Rev Dev Psychol. 2020;2:461\u201383.","journal-title":"Annu Rev Dev Psychol"},{"key":"461_CR36","doi-asserted-by":"publisher","first-page":"111108","DOI":"10.1016\/j.drugalcdep.2024.111108","volume":"256","author":"KA Hallgren","year":"2024","unstructured":"Hallgren KA, et al. Test-retest reliability of DSM-5 substance use symptom checklists used in primary care and mental health care settings. Drug Alcohol Depend. 2024;256:111108.","journal-title":"Drug Alcohol Depend"},{"key":"461_CR37","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1111\/jgs.17213","volume":"69","author":"BH Han","year":"2021","unstructured":"Han BH, Funk-White M, Ko R, Al-Rousan T, Palamar JJ. Decreasing perceived risk associated with regular cannabis use among older adults in the United States from 2015 to 2019. J Am Geriatr Soc. 2021;69:2591\u20137.","journal-title":"J Am Geriatr Soc"},{"key":"461_CR38","doi-asserted-by":"publisher","first-page":"108294","DOI":"10.1016\/j.drugalcdep.2020.108294","volume":"216","author":"D Hasin","year":"2020","unstructured":"Hasin D, et al. Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview. Drug Alcohol Depend. 2020;216:108294.","journal-title":"Drug Alcohol Depend"},{"key":"461_CR39","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","volume":"170","author":"DS Hasin","year":"2013","unstructured":"Hasin DS, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013;170:834\u201351.","journal-title":"Am J Psychiatry"},{"key":"461_CR40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1177\/1748895811415345","volume":"11","author":"AD Hathaway","year":"2011","unstructured":"Hathaway AD, Comeau NC, Erickson PG. Cannabis normalization and stigma: Contemporary practices of moral regulation. Criminol Crim Justice. 2011;11:451\u201369.","journal-title":"Criminol Crim Justice"},{"key":"461_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13722-018-0118-0","volume":"13","author":"DC Hodgins","year":"2018","unstructured":"Hodgins DC, Stea JN. Insights from individuals successfully recovered from cannabis use disorder: natural versus treatment-assisted recoveries and abstinent versus moderation outcomes. Addict Sci Clin Pract. 2018;13:16.","journal-title":"Addict Sci Clin Pract"},{"key":"461_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.drugalcdep.2008.03.031","volume":"97","author":"JR Hughes","year":"2008","unstructured":"Hughes JR, Peters EN, Callas PW, Budney AJ, Livingston AE. Attempts to stop or reduce marijuana use in non-treatment seekers. Drug Alcohol Depend. 2008;97:180\u20134.","journal-title":"Drug Alcohol Depend"},{"key":"461_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108169","volume":"214","author":"CM Jones","year":"2020","unstructured":"Jones CM, Noonan RK, Compton WM. Prevalence and correlates of ever having a substance use problem and substance use recovery status among adults in the United States, 2018. Drug Alcohol Depend. 2020;214:108169.","journal-title":"Drug Alcohol Depend"},{"key":"461_CR44","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.2174\/13816128113199990620","volume":"20","author":"L Karila","year":"2014","unstructured":"Karila L, et al. Acute and long-term effects of cannabis use: a review. Curr Pharm des. 2014;20:4112\u20138.","journal-title":"Curr Pharm des"},{"key":"461_CR45","doi-asserted-by":"publisher","first-page":"999","DOI":"10.15288\/jsad.2014.75.999","volume":"75","author":"LA Kaskutas","year":"2014","unstructured":"Kaskutas LA, et al. Elements that define recovery: the experiential perspective. J Stud Alcohol Drugs. 2014;75:999\u20131010.","journal-title":"J Stud Alcohol Drugs"},{"key":"461_CR46","doi-asserted-by":"crossref","unstructured":"Kenward MG, Roger JH, Small sample inference for fixed effects from restricted maximum likelihood. Biometrics. 1997;1:983\u201397.","DOI":"10.2307\/2533558"},{"key":"461_CR47","doi-asserted-by":"publisher","first-page":"282","DOI":"10.7326\/M18-0810","volume":"169","author":"S Keyhani","year":"2018","unstructured":"Keyhani S, et al. Risks and benefits of marijuana use: a national survey of US adults. Ann Intern Med. 2018;169:282\u201390.","journal-title":"Ann Intern Med"},{"key":"461_CR49","doi-asserted-by":"publisher","first-page":"101939","DOI":"10.1016\/j.cpr.2020.101939","volume":"82","author":"S Lake","year":"2020","unstructured":"Lake S, St Pierre M. The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: a systematic review. Clin Psychol Rev. 2020;82:101939.","journal-title":"Clin Psychol Rev"},{"key":"461_CR50","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/dar.12275","volume":"34","author":"N Lau","year":"2015","unstructured":"Lau N, et al. A safer alternative: Cannabis substitution as harm reduction: Cannabis substitution as harm reduction. Drug Alcohol Rev. 2015;34:654\u20139.","journal-title":"Drug Alcohol Rev"},{"key":"461_CR51","doi-asserted-by":"publisher","unstructured":"Lenth, R. emmeans: Estimated Marginal Means, Aka Least-Squares Means. (R Package Version 1.11.1). 2025. https:\/\/doi.org\/10.32614\/CRAN.package.emmeans","DOI":"10.32614\/CRAN.package.emmeans"},{"key":"461_CR52","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00213-021-06047-8","volume":"239","author":"J Leung","year":"2022","unstructured":"Leung J, et al. Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada. Psychopharmacology. 2022;239:1509\u201319.","journal-title":"Psychopharmacology"},{"key":"461_CR53","unstructured":"Lipari R, Jean-Francois B. Trends in perception of risk and availability of substance use among full-time college students. 2014. Retrieved from http:\/\/samhsa.gov\/data\/sites\/default\/files\/report_2418\/ShortReport-2418.html"},{"key":"461_CR54","doi-asserted-by":"publisher","first-page":"e2127002","DOI":"10.1001\/jamanetworkopen.2021.27002","volume":"4","author":"SS Martins","year":"2021","unstructured":"Martins SS, et al. Racial and ethnic differences in cannabis use following legalization in US States with medical cannabis laws. JAMA Netw Open. 2021;4:e2127002.","journal-title":"JAMA Netw Open"},{"key":"461_CR55","doi-asserted-by":"publisher","first-page":"e2316283","DOI":"10.1001\/jamanetworkopen.2023.16283","volume":"6","author":"TE Matson","year":"2023","unstructured":"Matson TE, et al. Psychometric performance of a substance use symptom checklist to help clinicians assess substance use disorder in primary care. JAMA Netw Open. 2023;6:e2316283.","journal-title":"JAMA Netw Open"},{"key":"461_CR56","doi-asserted-by":"publisher","first-page":"107552","DOI":"10.1016\/j.addbeh.2022.107552","volume":"138","author":"J Mennis","year":"2023","unstructured":"Mennis J, McKeon TP, Stahler GJ. Recreational cannabis legalization alters associations among cannabis use, perception of risk, and cannabis use disorder treatment for adolescents and young adults. Addict Behav. 2023;138:107552.","journal-title":"Addict Behav"},{"key":"461_CR57","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1300\/J175v04n01_04","volume":"4","author":"TH Mikuriya","year":"2004","unstructured":"Mikuriya TH. Cannabis as a substitute for alcohol: A harm-reduction approach. J Cannabis Therapeutics. 2004;4:79\u201393.","journal-title":"J Cannabis Therapeutics"},{"key":"461_CR58","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.drugalcdep.2014.06.006","volume":"142","author":"M Mojarrad","year":"2014","unstructured":"Mojarrad M, Samet JH, Cheng DM, Winter MR, Saitz R. Marijuana use and achievement of abstinence from alcohol and other drugs among people with substance dependence: a prospective cohort study. Drug Alcohol Depend. 2014;142:91\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"461_CR59","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1001\/jamapsychiatry.2022.2756","volume":"79","author":"R Mojtabai","year":"2022","unstructured":"Mojtabai R. Estimating the prevalence of substance use disorders in the US using the benchmark multiplier method. JAMA Psychiat. 2022;79:1074\u201380.","journal-title":"JAMA Psychiat"},{"key":"461_CR60","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1089\/can.2021.0229","volume":"8","author":"J Mok","year":"2023","unstructured":"Mok J, et al. Use of cannabis as a harm reduction strategy among people who use drugs: a cohort study. Cannabis Cannabinoid Res. 2023;8:670\u20138.","journal-title":"Cannabis Cannabinoid Res"},{"key":"461_CR61","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1111\/add.15417","volume":"116","author":"V Mongeau-P\u00e9russe","year":"2021","unstructured":"Mongeau-P\u00e9russe V, et al. Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo-controlled trial. Addiction. 2021;116:2431\u201342.","journal-title":"Addiction"},{"key":"461_CR62","unstructured":"NIDA. Marijuana and hallucinogen use among young adults reached all time-high in 2021. 2022. National Institute on Drug Abuse website https:\/\/nida.nih.gov\/news-events\/news-releases\/2022\/08\/marijuana-and-hallucinogen-use-among-young-adults-reached-all-time-high-in-2021.\u00a0Accessed 4 Aug 2023"},{"key":"461_CR63","doi-asserted-by":"publisher","unstructured":"Nist AN, Cabral DAR, Xu S, Tegge AN, Bickel WK. Rate of cross-commodity discounting of substances varies by substance type for individuals in recovery from substance use disorders. Exp Clin Psychopharmacol. https:\/\/doi.org\/10.1037\/pha0000780","DOI":"10.1037\/pha0000780"},{"key":"461_CR64","doi-asserted-by":"publisher","first-page":"102110","DOI":"10.1016\/j.cpr.2021.102110","volume":"91","author":"CE Paquette","year":"2022","unstructured":"Paquette CE, Daughters SB, Witkiewitz K. Expanding the continuum of substance use disorder treatment: Nonabstinence approaches. Clin Psychol Rev. 2022;91:102110.","journal-title":"Clin Psychol Rev"},{"key":"461_CR65","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/16066350500053703","volume":"13","author":"H Parker","year":"2005","unstructured":"Parker H. Normalization as a barometer: Recreational drug use and the consumption of leisure by younger Britons. Addict Res Theory. 2005;13:205\u201315.","journal-title":"Addict Res Theory"},{"key":"461_CR66","doi-asserted-by":"publisher","DOI":"10.1093\/her\/14.5.707","volume-title":"Illegal leisure: the normalisation of adolescent recreational drug use","author":"H Parker","year":"1998","unstructured":"Parker H, Aldrige J. Illegal leisure: the normalisation of adolescent recreational drug use. London: Routledge; 1998. https:\/\/doi.org\/10.1093\/her\/14.5.707."},{"key":"461_CR67","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.drugalcdep.2012.07.009","volume":"127","author":"K Peer","year":"2013","unstructured":"Peer K, et al. Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample. Drug Alcohol Depend. 2013;127:215\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"461_CR68","first-page":"689444","volume":"12","author":"GD Pearlson","year":"2021","unstructured":"Pearlson GD, Stevens MC, D\u2019Souza DC. Cannabis and driving. Front. Psychiatry. 2021;12:689444.","journal-title":"Psychiatry"},{"key":"461_CR69","doi-asserted-by":"publisher","first-page":"a039305","DOI":"10.1101\/cshperspect.a039305","volume":"11","author":"KZ Peters","year":"2021","unstructured":"Peters KZ, Oleson EB, Cheer JF. A brain on cannabinoids: The role of dopamine release in reward seeking and addiction. Cold Spring Harb Perspect Med. 2021;11:a039305.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"461_CR70","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/1753-6405.13030","volume":"44","author":"P Rawstorne","year":"2020","unstructured":"Rawstorne P, et al. Australian news media reporting of methamphetamine: an analysis of print media 2014\u20132016. Aust N Z J Public Health. 2020;44:468\u201375.","journal-title":"Aust N Z J Public Health"},{"key":"461_CR5","doi-asserted-by":"crossref","unstructured":"Reid M. A Qualitative Review of Cannabis Stigmas at the Twilight of Prohibition. J Cannabis Res. 2020;2(1):46.","DOI":"10.1186\/s42238-020-00056-8"},{"key":"461_CR71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1477-7517-6-35","volume":"6","author":"A Reiman","year":"2009","unstructured":"Reiman A. Cannabis as a substitute for alcohol and other drugs. Harm Reduct J. 2009;6:35.","journal-title":"Harm Reduct J"},{"key":"461_CR72","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1089\/can.2017.0012","volume":"2","author":"A Reiman","year":"2017","unstructured":"Reiman A, Welty M, Solomon P. Cannabis as a substitute for opioid-based pain medication: Patient self-report. Cannabis Cannabinoid Res. 2017;2:160\u20136.","journal-title":"Cannabis Cannabinoid Res"},{"key":"461_CR73","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1176\/appi.ps.20240329","volume":"76","author":"H Ringeisen","year":"2025","unstructured":"Ringeisen H, et al. Prevalence of past-year mental and substance use disorders, 2021\u20132022. Psychiatr Serv. 2025;76:720\u20138.","journal-title":"Psychiatr Serv"},{"key":"461_CR74","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1177\/02698811221115760","volume":"36","author":"KL Rock","year":"2022","unstructured":"Rock KL, Englund A, Morley S, Rice K, Copeland CS. Can cannabis kill? Characteristics of deaths following cannabis use in England (1998\u20132020). J Psychopharmacol. 2022;36:1362\u201370.","journal-title":"J Psychopharmacol"},{"key":"461_CR75","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing [computer software]. Vienna: R Foundation for Statistical Computing; 2025. https:\/\/www.r-project.org\/"},{"key":"461_CR76","doi-asserted-by":"publisher","first-page":"106818","DOI":"10.1016\/j.addbeh.2021.106818","volume":"116","author":"CP Salas-Wright","year":"2021","unstructured":"Salas-Wright CP, Hai AH, Oh S, Alsolami A, Vaughn MG. Trends in cannabis views and use among American adults: Intersections with alcohol consumption, 2002\u20132018. Addict Behav. 2021;116:106818.","journal-title":"Addict Behav"},{"key":"461_CR77","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1111\/acer.12838","volume":"39","author":"D Shmulewitz","year":"2015","unstructured":"Shmulewitz D, Greene ER, Hasin D. Commonalities and differences across substance use disorders: Phenomenological and epidemiological aspects. Alcohol Clin Exp Res. 2015;39:1878\u2013900.","journal-title":"Alcohol Clin Exp Res"},{"issue":"Suppl 1","key":"461_CR79","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1046\/j.1360-0443.97.s01.6.x","volume":"97","author":"RS Stephens","year":"2002","unstructured":"Stephens RS, Babor TF, Kadden R, Miller M, Marijuana Treatment Project Research Group. The marijuana treatment project: rationale, design and participant characteristics. Addiction. 2002;97(Suppl 1):109\u201324.","journal-title":"Addiction"},{"key":"461_CR80","doi-asserted-by":"publisher","first-page":"100312","DOI":"10.1016\/j.dadr.2024.100312","volume":"14","author":"MS Subbaraman","year":"2025","unstructured":"Subbaraman MS, Mahoney E, Mericle A, Polcin D. Cannabis use and alcohol-related outcomes among sober living house residents with alcohol use disorders. Drug Alcohol Depend Rep. 2025;14:100312.","journal-title":"Drug Alcohol Depend Rep"},{"key":"461_CR1","unstructured":"Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. Rockville: Substance Abuse and Mental Health Services Administration; 2020. NSDUH Series H-55, HHS Publication No. PEP20-07-01-001. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt29393\/2019NSDUHFFRPDFWHTML\/2019NSDUHFFR090120.htm"},{"key":"461_CR48","unstructured":"Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and Health. Rockville: Substance Abuse and Mental Health Services Administration; 2025. NSDUH Series H-60, HHS Publication No. PEP25-07-007. https:\/\/www.samhsa.gov\/data\/data-we-collect\/nsduh-national-survey-drug-use-and-health\/national-releases"},{"key":"461_CR81","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1477-7517-7-3","volume":"7","author":"R Swartz","year":"2010","unstructured":"Swartz R. Medical marijuana users in substance abuse treatment. Harm Reduct J. 2010;7:3.","journal-title":"Harm Reduct J"},{"key":"461_CR82","volume-title":"Modern Applied Statistics with S","author":"WN Venables","year":"2013","unstructured":"Venables WN, Ripley BD. Modern Applied Statistics with S. New York, NY: Springer; 2013."},{"key":"461_CR83","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/jamapediatrics.2020.6981","volume":"175","author":"ND Volkow","year":"2021","unstructured":"Volkow ND, Han B, Einstein EB, Compton WM. Prevalence of substance use disorders by time since first substance use among young people in the US. JAMA Pediatr. 2021;175:640\u20133.","journal-title":"JAMA Pediatr"},{"key":"461_CR84","doi-asserted-by":"publisher","first-page":"100228","DOI":"10.1016\/j.dadr.2024.100228","volume":"11","author":"CA Warnock","year":"2024","unstructured":"Warnock CA, Ondrusek AR, Edelman EJ, Kershaw T, Muilenburg JL. Perspectives regarding cannabis use: Results from a qualitative study of individuals engaged in substance use treatment in Georgia and Connecticut. Drug Alcohol Depend Rep. 2024;11:100228.","journal-title":"Drug Alcohol Depend Rep"},{"key":"461_CR85","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.drugalcdep.2016.01.014","volume":"161","author":"AH Weinberger","year":"2016","unstructured":"Weinberger AH, Platt J, Goodwin RD. Is cannabis use associated with an increased risk of onset and persistence of alcohol use disorders? A three-year prospective study among adults in the United States. Drug Alcohol Depend. 2016;161:363\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"461_CR86","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11121-018-0903-8","volume":"20","author":"H Wen","year":"2019","unstructured":"Wen H, Hockenberry JM, Druss BG. The effect of medical marijuana laws on marijuana-related attitude and perception among US adolescents and young adults. Prev Sci. 2019;20:215\u201323.","journal-title":"Prev Sci"},{"key":"461_CR87","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S2215-0366(26)00015-5","volume":"13","author":"J Wilson","year":"2026","unstructured":"Wilson J, et al. The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2026;13:304\u201315.","journal-title":"Lancet Psychiatry"},{"key":"461_CR88","doi-asserted-by":"crossref","unstructured":"Witkiewitz K, Montes KS, Schwebel FJ, Tucker JA. What Is recovery? Alcohol Research: Current Reviews 2020;40(3):01.","DOI":"10.35946\/arcr.v40.3.01"},{"key":"461_CR89","unstructured":"World Drug Report 2021. https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/wdr2021.html."},{"key":"461_CR90","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1001\/jamainternmed.2024.3270","volume":"184","author":"KC Young-Wolff","year":"2024","unstructured":"Young-Wolff KC, et al. Prenatal cannabis use and maternal pregnancy outcomes. JAMA Intern Med. 2024;184:1083\u201393.","journal-title":"JAMA Intern Med"},{"key":"461_CR91","doi-asserted-by":"publisher","unstructured":"Yu B, Chen X, Chen X, Yan H. Marijuana legalization and historical trends in marijuana use among US residents aged 12\u201325: results from the 1979\u20132016 National Survey on drug use and health. BMC Public Health. 2020;20. Preprint at https:\/\/doi.org\/10.1186\/s12889-020-8253-4.","DOI":"10.1186\/s12889-020-8253-4"},{"key":"461_CR92","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s11481-018-9782-9","volume":"13","author":"A Zehra","year":"2018","unstructured":"Zehra A, et al. Cannabis view. J Neuroimmune Pharmacol. 2018;13:438\u201352.","journal-title":"J Neuroimmune Pharmacol"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-026-00461-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00461-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00461-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:50:54Z","timestamp":1790916654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42238-026-00461-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["461"],"URL":"https:\/\/doi.org\/10.1186\/s42238-026-00461-5","relation":{},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board at Virginia Polytechnic State University.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"102"}}